Gene · 839
NIH grants1,719
NIH grants whose papers are about the gene, through NIH's grant-paper links.
501 to 520 of 1,719
Download this page as JSON| Grant | Title | CASP6 papers | Newest fiscal year |
|---|---|---|---|
| I01BX003328 | Overcoming BRAF and MEK Inhibitors Resistance in Advanced Melanoma | 1 | 2019 |
| K02AA018755 | Genes, Environments & Interventions: Understanding and Addressing Alcohol Misuse | 1 | 2019 |
| K08CA191058 | Elucidating and overcoming endocrine resistance driven by ESR1 mutations | 1 | 2019 |
| K22CA204439 | Quantitative Modeling for Chromatin Regulation of Gene Expression in Cancer | 1 | 2019 |
| K99HL143277 | Protective Effects of Amlexanox Against Atherosclerosis | 1 | 2019 |
| P01CA190174 | Immunologic Approaches to Ovarian Cancer | 1 | 2019 |
| P01HL075443 | Novel Mechanisms and Therapies in Heart Failure | 1 | 2019 |
| P30DK072488 | Mid-Atlantic Nutrition Obesity Research Center | 1 | 2019 |
| P42ES007381 | Superfund Research Program at Boston University | 1 | 2019 |
| P50AG005136 | Alzheimer's Disease Research Center | 1 | 2019 |
| P50GM115318 | Pharmacogenomics of Statin Therapy | 1 | 2019 |
| P50NS038377 | Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50) | 1 | 2019 |
| R01AG047976 | Spinal cord and brainstem pathology contributions to late-life gait impairment | 1 | 2019 |
| R01AI044924 | IFN-Gamma Gene Regulation in T Cells and NK Cells | 1 | 2019 |
| R01AI052203 | Programming protective immunity by targeting antigens to the CD180 receptor | 1 | 2019 |
| R01AI119065 | Role of SCARF1 in apoptotic cell clearance and prevention of autoimmunity | 1 | 2019 |
| R01AI119073 | Role of caspase-11 in innate immunity | 1 | 2019 |
| R01AI125390 | Proteomics of eosinophil activation | 1 | 2019 |
| R01CA072851 | Familial and Early Onset Colorectal Cancer | 1 | 2019 |
| R01CA082214 | Reporter Gene Technologies for Integrated Cancer Diagnostics | 1 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/839/grants?page=26